Effect of Intravenous Dexmedetomidine on Patient Discomfort in Laparoscopic Cholecystectomy Under Spinal Anesthesia.
Launched by THEODOR BILHARZ RESEARCH INSTITUTE · Oct 2, 2019
Trial Information
Current as of August 11, 2025
Unknown status
Keywords
ClinConnect Summary
This is a prospective, randomized double blinded control study which will be conducted in department of anesthesia and surgical Intensive care unit at Theodor Bilharz Research Institute after approval by research ethics committee and patient informed consent. 40 patients will be enrolled in the study and divided into two groups 20 patients each ; either (Dexa group (D) or Control group (C).
Anesthesia Technique:
A preoperative assessment, including a history, physical examination, review of laboratory data, and assignment of ASA classification will be performed on all patients prior to th...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA 1-2.
- • Patients undergoing elective laparoscopic Cholecystectomy with estimated pneumoperitoneum time of 60 to 90 min.
- Exclusion Criteria:
- • Pregnancy.
- • Lactating women.
- • Any contraindication to spinal anesthesia e.g. Bleeding diathesis, infection at the puncture site, patient on anticoagulants or preexisting neurological deficits in lower extremities.
- • Patients on α2-adrenergic receptors antagonists, calcium channel blockers, or angiotensin-converting enzyme inhibitors.
- • Patients known allergic to bupivacaine or dexmedetomidine
About Theodor Bilharz Research Institute
Theodor Bilharz Research Institute is a leading research organization dedicated to advancing the understanding and treatment of infectious diseases, particularly schistosomiasis and other parasitic infections. Established with a commitment to scientific excellence, the Institute conducts innovative clinical trials and translational research to develop effective interventions and improve public health outcomes. With a multidisciplinary team of experts, the Institute collaborates with national and international partners to enhance research capabilities and foster the translation of findings into clinical practice, ultimately aiming to reduce the burden of infectious diseases in affected populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Moshira S Mohamed, MD
Principal Investigator
Theodor Bilharz Research Institute
Hend F Hassan, MD
Study Chair
Theodor Bilharz Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials